Daniel Shames
Vermögen: - $ am 31.08.2026
Vermögen: - $ am 31.08.2026
Daniel Shames is the founder of Carolina Urocorp, Inc. Dr. Shames is an Independent Non-Executive Director at Mereo BioPharma Group Plc since 2022.
Formerly, Dr. Shames was Deputy Director-Office of Drug Evaluation III at the US Food & Drug Administration from 2006 to 2008.
Dr. Shames was President of Daniel A Shames Consulting, Inc. Dr. Shames completed undergraduate studies at Brandeis University and earned a doctorate from Georgetown University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 26.03.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Direktor/Vorstandsmitglied | 10.11.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01.01.2008 |
Daniel A Shames Consulting, Inc. | Präsident | - |
Carolina Urocorp, Inc. | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Georgetown University School of Medicine
Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Carolina Urocorp, Inc. | |
Daniel A Shames Consulting, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen